WASHINGTON (AP) — A $1,000-per-pill drug that insurers are reluctant to pay for has quickly become the treatment of choice for a liver-wasting viral disease that affects more than 3 million Americans.
source U.S. News http://ift.tt/1qeEOSd
source U.S. News http://ift.tt/1qeEOSd
ليست هناك تعليقات :
إرسال تعليق